NASDAQ: EVGN
Evogene Ltd Stock Ownership - Who owns Evogene?

Insider buying vs selling

Have Evogene Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when EVGN insiders and whales buy or sell their stock.

EVGN Shareholders

What type of owners hold Evogene Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Citadel Advisors LLC1.02%88,764$72.70kInstitution
Leon Recanati0.96%83,886$68.70kInsider
Jane Street Group LLC0.44%37,942$31.07kInstitution
Xtx Topco Ltd0.26%22,684$18.58kInstitution
Bnp Paribas Financial Markets0.12%10,124$8.29kInstitution
Daytona Street Capital LLC0.11%9,586$7.85kInstitution
Morgan Stanley0.10%9,051$7.41kInstitution
Yaron Eldad0.05%4,100$3.36kInsider
Ubs Group Ag0.01%1,197$980.34Institution
Altshuler Shaham Ltd0.01%750$614.25Institution

1 of 3

EVGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EVGN2.08%1.01%
IMRN0.05%0.00%
TCRT0.39%99.61%Net BuyingNet Buying
ARTL10.57%89.43%
XBIO5.33%94.67%

Evogene Stock Ownership FAQ

Who owns Evogene?

Evogene (NASDAQ: EVGN) is owned by 2.08% institutional shareholders, 1.01% Evogene insiders, and 96.91% retail investors. Leon Recanati is the largest individual Evogene shareholder, owning 83,886.00 shares representing 0.96% of the company. Leon Recanati's Evogene shares are currently valued at $61.66k.

If you're new to stock investing, here's how to buy Evogene stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.